Michael D. Dale, Chief Executive Officer at ATS MEDICAL INC (ATSI), sold 16,380 shares at $2.37 ($39K) on 2007-03-02, disclosed to the SEC on 2007-03-05.
Scheduled sale ($39k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.31 | 1,000 | $2K | 6.0% |
| 2 | $2.33 | 1,000 | $2K | 6.0% |
| 3 | $2.35 | 1,000 | $2K | 6.1% |
| 4 | $2.37 | 30 | $71 | 0.2% |
| 5 | $2.37 | 8,150 | $19K | 49.8% |
| 6 | $2.38 | 5,200 |
| $12K |
| 31.9% |
| Total | $2.37 avg | 16,380 | $39K | 100% |
| Filing → |
| ABT | SELL | 2023-03-02 | $243K | — | Filing → |
| ABT | SELL | 2022-03-10 | $468K | — | Filing → |
| ABT | SELL | 2022-03-02 | $249K | — | Filing → |